When did Boundless Bio (BOLD) last report earnings?

Boundless Bio last reported on Aug 5, 2025, covering fiscal Q2 2025.

Did BOLD beat earnings estimates?

No. Boundless Bio reported EPS of −$0.70 for Q2 2025 against a −$0.65 estimate — a 7.69% miss.

Boundless Bio (BOLD) earnings history

Most recent quarter

Fiscal period: Q2 2025
Period end: Jun 30, 2025
EPS actual: −$0.70
EPS estimate: −$0.65
EPS surprise: −7.69%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Aug 5, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2025	Aug 5, 2025	−$0.65	−$0.70	−7.69%	$0.00	SEC
Q1 2025	May 9, 2025	−$0.74	−$0.71	+3.40%	$0.00	SEC
Q2 2024	Aug 12, 2024	−$0.80	−$0.77	+3.75%	$0.00	SEC

Quarterly revenue

Q2 2024

$0.00

Q1 2025

$0.00

Q2 2025

$0.00

Frequently asked questions

When did Boundless Bio (BOLD) last report earnings?
Boundless Bio last reported on Aug 5, 2025, covering fiscal Q2 2025.
Did BOLD beat earnings estimates?
No. Boundless Bio reported EPS of −$0.70 for Q2 2025 against a −$0.65 estimate — a 7.69% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by